Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
600 participants
INTERVENTIONAL
2013-08-31
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators propose a 4 year project to test the effectiveness of a cognitive-behavioural intervention that the investigators have designed to support developmentally appropriate disclosure to HIV infected children by their caregiver.
The investigators hypothesize that the intervention will lead to increased disclosure rates and will over time improve health and mental health outcomes among caregivers and children in the intervention group compared to those receiving standard care. The findings of the study will inform Ugandan and other countries' national policies on pediatric HIV care and treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of a Counselling Intervention on the Uptake of HIV Care Services Among HIV Infected Patients in Uganda
NCT02497456
Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Uganda
NCT04774666
Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children
NCT00429546
Enhancing Ugandan HIV-Affected Child Development With Caregiver Training
NCT01640561
Enhancing Uptake of Family Planning Services by HIV-Infected Women Attending the PMTCT Program
NCT03019601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study proposes to test the effectiveness of an innovative cognitive-behavioural intervention designed to support developmentally appropriate disclosure to HIV-infected children by their caregiver. The proposed intervention builds on the investigators' team's prior research is informed by a cognitive behavioral perspective, as well as the Disclosure Processes Model. The investigators will also adapt components of a multi-faceted program for caregivers of HIV-infected children, developed by members of the investigators' team with funding support from the US President's Emergency Plan for AIDS Relief (PEPFAR).
Specific aims:
1. To determine the effectiveness of a cognitive-behavior intervention for increasing disclosure of children's HIV diagnosis by caregivers to their HIV-infected children age 7-12 years old in Uganda.
2. To determine the effect of disclosure on immediate and longer-term caregiver and child mental health, and child behavioral and clinical outcomes, and whether the intervention modifies these effects
3. To assess the incremental cost, health impact, and cost-effectiveness of the intervention
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive-behavioral intervention
A cognitive-behavioural intervention aimed at supporting caregivers through paediatric HIV diagnosis disclosure to the child in their care.
Cognitive behavioral intervention to support pediatric HIV disclosure
Standard of Care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive behavioral intervention to support pediatric HIV disclosure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed HIV-infected;
* unaware of their HIV status, according to caregiver report;
* principal caregiver, age 18 years or older, of the eligible study child is able and willing to participate in their regular treatment program (monthly visits) and data collection visits at the study clinic at 6-month intervals for 24 months;
* agreement to participate in 3 group sessions with other caregivers over a 6 week period, and 3 counseling session with the eligible child(ren), scheduled at the same time as usual clinic visits;
* resides within a 30km radius around the study clinic, and not planning on moving during the study period; caregiver and child must both consent / assent for participation.
Exclusion Criteria
* for children, medical history of serious birth complications, severe malnutrition, bacterial meningitis, encephalitis, cerebral malaria, or other known brain injury or disorder requiring hospitalization or continued evidence of seizure or other neurological disability;
* for caregivers, severe mental illness or developmental disability.
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MU-JHU CARE
OTHER
University of Connecticut
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa Butler
Associate Research Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa M Butler
Role: PRINCIPAL_INVESTIGATOR
U Connecticut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kampala City Council Authority (KCCA) Kiswa Health Centre
Kampala, , Uganda
KCCA Kawaala Health Centre
Kampala, , Uganda
KCCA Kisenyi Health Centre
Kampala, , Uganda
KCCA Kitebi Health Centre
Kampala, , Uganda
Makerere University-Johns Hopkins University Research Collaboration (MUJHU) clinic
Kampala, , Uganda
Nsambya Health Clinic
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pediatric HIV Disclosure
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.